Biosecurity
(n.) The application of modern tools of biotechnology, at scale, to counter biological threats in all forms and origins.
We are defining the biosecurity landscape
Just as the advent of the information age underscored the need for countries to invest in cyber security to protect their national interests, novel biological threats demand prioritizing biosecurity for a healthy, secure future.
Our objective is to build a global network of monitored nodes that enables the detection, analysis, and rapid response to biological threats.
To build this network, the product we deploy is a “bio-radar” system that collects and processes threat information from areas of biological risk to empower national security and public health decision making.
Our systems leverage AI-enabled threat models and predictive capacity to identify and characterize where the next biological risks are emerging, giving governments an early warning and driving actionable insights to empower informed decision making.
Systems for a resilient future
Since 2021, we’ve delivered COVID-19 testing to schools, senior living centers, and other vulnerable populations across more than 30 U.S. states. And as the threat evolved, so did we.
With the Centers for Disease Control and Prevention (CDC) and XpresCheck, we developed the Travelers Genomic Surveillance (TGS) program in international airports around the U.S. and delivered the nation’s first aircraft wastewater surveillance program using proprietary devices.
As our international offerings grew, we worked with industry-leading researchers to develop and validate new methods for multi-pathogen testing and surveillance, epidemiological risk modeling, and bioinformatics analysis.
We expanded to ports of entry and borders, farms, hospitals, and other locations that pose a high risk for the next emerging biological threats. By integrating systems across multiple sectors, we became the only global biosecurity firm with an end-to-end, state of the art solution to mitigate the risks from harmful biology.
For resilience across all our systems, from food security, to health security, to ecological security, to national security, we are building the evolution of biosecurity.
Ginkgo’s Foundry supercharges our offerings
Concentric is the biosecurity unit of Ginkgo Bioworks, the leading horizontal platform for cell programming. Working together gives us the power to add biosecurity at the point of design.
Ginkgo’s Foundry is home to the best of DNA synthesis, sequencing, laboratory automation, and high-performance analytics. It’s where we sequenced the first instances of Omicron BA.2 and BA.3 in the U.S. as part of the CDC’s traveler-based early detection program.
Building our offerings around the Foundry magnifies our knowledge of genomics. What we learn there can help accelerate effective responses — like vaccine development — and ensure we are building proper safety and security measures into new technologies from the start.
